Lexeo Therapeutics Quote - LXEO

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

14.89

Bid

13.00

Offer

16.51

Volume

96,024

13.78 Day's Range 15.75

9.00 52 Week Range 22.33

Market Cap

490.556M

Previous Close

14.02

Open

13.78

Last Trade

15.2

Last Trade Time

Financial Volume

US$ 1,376,021

VWAP

14.33

Average Volume (3m)

161,569

Shares Outstanding

32,945,341

Dividend Yield

PE Ratio

-7.39

Earnings Per Share (EPS)

-2.02

Revenue

Net Profit

-66.39M

Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene t... Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.lexeotx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Lexeo Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker LXEO. The last closing price for Lexeo Therapeutics was US$14.02. Over the last year, Lexeo Therapeutics shares have traded in a share price range of US$ 9.00 to US$ 22.33.

Lexeo Therapeutics currently has 32,945,341 shares in issue. The market capitalisation of Lexeo Therapeutics is US$490.56 million. Lexeo Therapeutics has a price to earnings ratio (PE ratio) of -7.39.

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.73	-10.4091456077	16.62	17.36	13.65	236016	14.65139234	CS
4	-2.18	-12.7709431752	17.07	19.14	13.65	225400	16.69321211	CS
12	1.54	11.5355805243	13.35	19.14	11.57	161569	15.122935	CS
26	0.39	2.68965517241	14.5	22.33	11.57	130881	15.26584773	CS
52	5.39	56.7368421053	9.5	22.33	9	135250	14.44663459	CS
156	5.39	56.7368421053	9.5	22.33	9	135250	14.44663459	CS
260	5.39	56.7368421053	9.5	22.33	9	135250	14.44663459	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BYHOBryah Resources Ltd	AUD 0.002 (100.00%)	240k
VPRVolt Group Ltd	AUD 0.002 (33.33%)	414.96k
EUROBEuropean Lithium Limited	AUD 0.004 (33.33%)	170k
BASOBass Oil Limited	AUD 0.004 (33.33%)	382.89k
MHCManhattan Corporation Limited	AUD 0.002 (33.33%)	376k
G88OAGolden Mile Resources Ltd	AUD 0.001 (-66.67%)	4k
ECGeCargo Holdings Limited	AUD 0.008 (-57.89%)	3.57M
RMLResolution Minerals Ltd	AUD 0.002 (-33.33%)	2.71M
CLZClassic Minerals Limited	AUD 0.001 (-33.33%)	15.88M
1TTThrive Tribe Technologies Ltd	AUD 0.003 (-25.00%)	4.63M
88E88 Energy Limited	AUD 0.002 (0.00%)	303.71M
NHCNew Hope Corporation Limited	AUD 5.04 (-4.00%)	39.06M
EEGEmpire Energy Group Ltd	AUD 0.245 (0.00%)	30.33M
MMIMetro Mining Ltd	AUD 0.055 (6.80%)	23.54M
TX3Trinex Minerals Ltd	AUD 0.003 (0.00%)	17.74M